AAAAAA
Results:
1-20
|
Results: 20
Authors:
Rudat, V
Wannenmacher, M
Citation: V. Rudat et M. Wannenmacher, Role of multimodal treatment in oropharynx, larynx, and hypopharynx cancer, SEM SURG ON, 20(1), 2001, pp. 66-74
Authors:
Rudat, V
Bachmann, N
Kupper, JH
Weber, KJ
Citation: V. Rudat et al., Overexpression of the DNA-binding domain of poly(ADP-ribose) polymerase inhibits rejoining of ionizing radiation-induced DNA double-strand breaks, INT J RAD B, 77(3), 2001, pp. 303-307
Authors:
Momm, F
Bechtold, C
Rudat, V
Strnad, V
Tsekos, A
Fischer, K
Henke, M
Citation: F. Momm et al., Alteration of radiation-induced hematotoxicity by amifostine, INT J RAD O, 51(4), 2001, pp. 947-951
Authors:
Staar, S
Rudat, V
Stuetzer, H
Dietz, A
Volling, P
Schroeder, M
Flentje, M
Eckel, HE
Mueller, RP
Citation: S. Staar et al., Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - Results of a multicentric randomized German trial in advanced head-and-neck cancer (vol 50, pg 1161, 2001), INT J RAD O, 51(2), 2001, pp. 569-569
Authors:
Staar, S
Rudat, V
Stuetzer, H
Dietz, A
Volling, P
Schroeder, M
Flentje, M
Eckel, HE
Mueller, RP
Citation: S. Staar et al., Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer, INT J RAD O, 50(5), 2001, pp. 1161-1171
Authors:
Rudat, V
Stadler, P
Becker, A
Vanselow, B
Dietz, A
Wannemacher, M
Molls, M
Dunst, J
Feldmann, HJ
Citation: V. Rudat et al., Predictive value of the tumor oxygenation by means of pO(2) histography inpatients with advanced head and neck cancer, STRAH ONKOL, 177(9), 2001, pp. 462-468
Authors:
Dietz, A
Rudat, V
Conradt, C
Weidauer, H
Ho, A
Moehler, T
Citation: A. Dietz et al., Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy, HEAD NECK, 22(7), 2000, pp. 666-673
Authors:
Brizel, DM
Wasserman, TH
Henke, M
Strnad, V
Rudat, V
Monnier, A
Eschwege, F
Zhang, J
Russell, L
Oster, W
Sauer, R
Citation: Dm. Brizel et al., Phase III randomized trial of amifostine as a radioprotector in head and neck cancer, J CL ONCOL, 18(19), 2000, pp. 3339-3345
Authors:
Rudat, V
Meyer, J
Momm, F
Bendel, M
Henke, M
Strnad, V
Grotz, K
Schulte, A
Citation: V. Rudat et al., Protective effect of amifostine on dental health after radiotherapy of thehead and neck, INT J RAD O, 48(5), 2000, pp. 1339-1343
Authors:
Vanselow, B
Eble, MJ
Rudat, V
Wollensack, P
Conradt, C
Dietz, A
Citation: B. Vanselow et al., Oxygenation of advanced head and neck cancer: Prognostic marker for the response to primary radiochemotherapy, OTO H N SUR, 122(6), 2000, pp. 856-862
Authors:
Dietz, A
Delorme, S
Rudat, V
Zuna, I
Conradt, C
Vanselow, B
Weidauer, H
Citation: A. Dietz et al., Prognostic assessment of sonography and tumor volumetry in advanced cancerof the head and neck by use of Doppler ultrasonography, OTO H N SUR, 122(4), 2000, pp. 596-601
Authors:
Rudat, V
Vanselow, B
Wollensack, P
Bettscheider, C
Osman-Ahmet, S
Eble, MJ
Dietz, A
Citation: V. Rudat et al., Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer, RADIOTH ONC, 57(1), 2000, pp. 31-37
Authors:
Dietz, A
Rudat, V
Conradt, C
Vanselow, B
Wollensack, P
Staar, S
Eckel, H
Volling, P
Schroder, M
Wannenmacher, M
Muller, RP
Weidauer, H
Citation: A. Dietz et al., Prognostic significance of initial hemoglobin in head and neck cancer treated by primary chemoradiation, HNO, 48(9), 2000, pp. 655-664
Rise of oxygenation in cervical lymph node metastasis during the initial course of radiochemotherapy
Authors:
Dietz, A
Rudat, V
Vanselow, B
Wollensack, P
Bettscheider, C
Conradt, C
Elbe, MJ
Citation: A. Dietz et al., Rise of oxygenation in cervical lymph node metastasis during the initial course of radiochemotherapy, OTO H N SUR, 121(6), 1999, pp. 789-796
Authors:
Rudat, V
Dietz, A
Nollert, J
Conradt, C
Weber, KJ
Flentje, M
Wannenmacher, M
Citation: V. Rudat et al., Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancerafter concomitant boost radiochemotherapy, RADIOTH ONC, 53(3), 1999, pp. 233-245
Authors:
Rudat, V
Dietz, A
Schramm, O
Conradt, C
Maier, H
Flentje, M
Wannenmacher, M
Citation: V. Rudat et al., Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy, RADIOTH ONC, 53(2), 1999, pp. 119-125
Authors:
Haas, S
Bosch, FX
Klein-Kuhne, W
Nollert, J
Rudat, V
Conradt, C
Dietz, A
Citation: S. Haas et al., Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer, HNO, 47(9), 1999, pp. 777
Authors:
Dietz, A
Rudat, V
Vanselow, B
Conradt, C
Mohler, T
Citation: A. Dietz et al., Predictive value of serum levels of basic fibroblast growth factor, vascular endothelial growth factor and matrix metalloproteinase-2 in advanced carcinomas of the head and neck, HNO, 47(8), 1999, pp. 695-701
Authors:
Nollert, J
Rudat, V
Daniel, V
Maier, H
Dietz, A
Citation: J. Nollert et al., Immunomodulating effects of chemoradiation therapy in patients suffering from tumors in head and neck, HNO, 47(12), 1999, pp. 1058-1062
Authors:
Schlemmer, HP
Becker, M
Bachert, P
Dietz, A
Rudat, V
Vanselow, B
Wollensack, P
Zuna, I
Knopp, MV
Weidauer, H
Wannenmacher, F
van Kaick, G
Citation: Hp. Schlemmer et al., Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head andneck carcinoma during simultaneous radiochemotherapy, CANCER RES, 59(10), 1999, pp. 2363-2369
Risultati:
1-20
|